{"id":48327,"date":"2022-09-13T19:01:52","date_gmt":"2022-09-13T17:01:52","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\/"},"modified":"2022-09-13T19:01:52","modified_gmt":"2022-09-13T17:01:52","slug":"bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\/","title":{"rendered":"Bipolar Disorder Therapeutics Global Market Report 2022: Increase in the Prevalence of Bipolar Disorder to Drive Growth &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5648182\/bipolar-disorder-therapeutics-global-market?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=nmj233&amp;utm_campaign=1749301+-+Bipolar+Disorder+Therapeutics+Global+Market+Report+2022%3A+Increase+in+the+Prevalence+of+Bipolar+Disorder+to+Drive+Growth&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Bipolar Disorder Therapeutics Global Market Report 2022&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220913006125\/en\/1570464\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220913006125\/en\/1570464\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global bipolar disorder therapeutics market is expected to grow from $6.00 billion in 2021 to $6.47 billion in 2022 at a compound annual growth rate (CAGR) of 7.8%. The bipolar disorder therapeutics market is expected to grow to $7.67 billion in 2026 at a CAGR of 4.4%.\n<\/p>\n<p>\nNorth America was the largest region in the bipolar disorder therapeutics market in 2021. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the bipolar disorder therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.\n<\/p>\n<p>\nThe increase in the prevalence of bipolar disorder is expected to propel the growth of the bipolar disorder therapeutics market going forward. Bipolar disorder refers to a disabling illness that is associated with depressive mood swings and includes symptoms such as irregular sleep, low motivation, and loss of interest in daily activities.\n<\/p>\n<p>\nPopulation growth and aging are leading to an increase in the burden of bipolar disorder over time. As a result, an increase in the prevalence of bipolar disorder increases the demand for the bipolar disorder therapeutics market. For instance, in 2019, according to the World Health Organization, a Switzerland-based government agency, the number of people affected by bipolar disorder stood at 45 million. Therefore, the increase in the prevalence of bipolar disorder is driving the growth of the bipolar disorder therapeutics market.\n<\/p>\n<p>\nStrategic partnerships have emerged as a key trend gaining popularity in the bipolar disorder therapeutics market. Major companies operating in the bipolar disorder therapeutics sector are focused on partnerships to reinforce their position.\n<\/p>\n<p>\nFor instance, in October 2021, Mindpax Inc., a Germany-based digital technology company operating in the bipolar disorder therapeutics market, partnered with Eversana Life Science Services LLC, a US-based life sciences company operating in the bipolar disorder therapeutics market. Through this partnership, both companies will develop remote clinical assessments and targeted digital therapy to improve patients&#8217; clinical conditions and provide personalized therapeutic interventions to bipolar patients.\n<\/p>\n<p>\nFurthermore, in November 2020, Biogen, a US-based biotechnology company, partnered with Sage Therapeutics, a US-based company that develops novel therapies including bipolar. Through this partnership, both businesses will work together to commercialize zuranolone (SAGE-217) for significant postpartum depression (PPD), depressive disorder (MDD), and other psychiatric diseases.\n<\/p>\n<p>\nIn May 2020, AbbVie, a US-based biopharmaceutical company, acquired Allergan plc for a deal amount of $63 billion. AbbVie&#8217;s revenue base is expected to broaden and diversify, complementing existing leadership positions in immunology (with Humira (adalimumab) and hematologic oncology (with Imbruvica (ibrutinib) and Venclexta (upadacitinib), and the recently launched Skyrizi (risankizumab) and Rinvoq (upadacitinib) (venetoclax). Allergan is an Ireland-based specialty pharmaceutical company that develops pharmaceuticals and biosimilar products, including those for bipolar disorder.\n<\/p>\n<p>\n<strong>Scope<\/strong>\n<\/p>\n<p>\n<strong>Markets Covered:<\/strong>\n<\/p>\n<p>\n1) By Drug Class: Mood Stabilizers; Antipsychotic Drugs; Antidepressant Drugs; Other Drugs\n<\/p>\n<p>\n2) By Mechanism: Selective Serotonin Reuptake Inhibitors; Serotonin-norepinephrine Reuptake Inhibitors; Tricyclic Antidepressants; Monoamine Oxidase Inhibitors; Benzodiazepines; Beta-Blockers; Other Mechanisms\n<\/p>\n<p>\n3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies\n<\/p>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1. Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>2. Bipolar Disorder Therapeutics Market Characteristics<\/strong>\n<\/p>\n<p>\n<strong>3. Bipolar Disorder Therapeutics Market Trends And Strategies<\/strong>\n<\/p>\n<p>\n<strong>4. Impact Of COVID-19 On Bipolar Disorder Therapeutics<\/strong>\n<\/p>\n<p>\n<strong>5. Bipolar Disorder Therapeutics Market Size And Growth<\/strong>\n<\/p>\n<p>\n<strong>6. Bipolar Disorder Therapeutics Market Segmentation<\/strong>\n<\/p>\n<p>\n<strong>7. Bipolar Disorder Therapeutics Market Regional And Country Analysis<\/strong>\n<\/p>\n<p>\n<strong>8. Asia-Pacific Bipolar Disorder Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>9. China Bipolar Disorder Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>10. India Bipolar Disorder Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>11. Japan Bipolar Disorder Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>12. Australia Bipolar Disorder Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>13. Indonesia Bipolar Disorder Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>14. South Korea Bipolar Disorder Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>15. Western Europe Bipolar Disorder Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>16. UK Bipolar Disorder Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>17. Germany Bipolar Disorder Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>18. France Bipolar Disorder Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>19. Eastern Europe Bipolar Disorder Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>20. Russia Bipolar Disorder Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>21. North America Bipolar Disorder Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>22. USA Bipolar Disorder Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>23. South America Bipolar Disorder Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>24. Brazil Bipolar Disorder Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>25. Middle East Bipolar Disorder Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>26. Africa Bipolar Disorder Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>27. Bipolar Disorder Therapeutics Market Competitive Landscape And Company Profiles<\/strong>\n<\/p>\n<p>\n<strong>28. Key Mergers And Acquisitions In The Bipolar Disorder Therapeutics Market<\/strong>\n<\/p>\n<p>\n<strong>29. Bipolar Disorder Therapeutics Market Future Outlook and Potential Analysis<\/strong>\n<\/p>\n<p>\n<strong>30. Appendix<\/strong>\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAbbVie Inc.\n<\/li>\n<li>\nPfizer Inc.\n<\/li>\n<li>\nAstellas Pharma Inc.\n<\/li>\n<li>\nAstraZeneca PLC\n<\/li>\n<li>\nBristol-Myers Squibb\n<\/li>\n<li>\nGlaxoSmithKline PLC\n<\/li>\n<li>\nJanssen Pharmaceuticals\n<\/li>\n<li>\nNovartis AG\n<\/li>\n<li>\nOtsuka Pharmaceutical Co. Ltd.\n<\/li>\n<li>\nValidus Pharmaceuticals\n<\/li>\n<li>\nEli Lilly and Company\n<\/li>\n<li>\nGedeon Richter Plc\n<\/li>\n<li>\nSumitomo Pharma Co. Ltd.\n<\/li>\n<li>\nH. Lundbeck A\/S\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5648182\/bipolar-disorder-therapeutics-global-market?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=nmj233&amp;utm_campaign=1749301+-+Bipolar+Disorder+Therapeutics+Global+Market+Report+2022%3A+Increase+in+the+Prevalence+of+Bipolar+Disorder+to+Drive+Growth&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/e1z64c<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#97;&#x69;&#x6c;&#116;&#111;&#x3a;&#x70;&#114;&#101;&#x73;&#x73;&#64;&#114;&#x65;&#x73;&#101;&#97;&#x72;&#x63;&#104;&#97;&#x6e;&#x64;&#109;&#97;&#x72;&#x6b;&#101;&#116;&#x73;&#x2e;&#99;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;e&#115;&#x73;&#64;&#114;&#x65;s&#x65;&#x61;&#114;&#x63;h&#97;&#x6e;d&#109;&#x61;r&#x6b;&#x65;&#116;&#x73;&#x2e;&#99;&#x6f;m<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Bipolar Disorder Therapeutics Global Market Report 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global bipolar disorder therapeutics market is expected to grow from $6.00 billion in 2021 to $6.47 billion in 2022 at a compound annual growth rate (CAGR) of 7.8%. The bipolar disorder therapeutics market is expected to grow to &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48327","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bipolar Disorder Therapeutics Global Market Report 2022: Increase in the Prevalence of Bipolar Disorder to Drive Growth - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bipolar Disorder Therapeutics Global Market Report 2022: Increase in the Prevalence of Bipolar Disorder to Drive Growth - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Bipolar Disorder Therapeutics Global Market Report 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global bipolar disorder therapeutics market is expected to grow from $6.00 billion in 2021 to $6.47 billion in 2022 at a compound annual growth rate (CAGR) of 7.8%. The bipolar disorder therapeutics market is expected to grow to ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-13T17:01:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220913006125\/en\/1570464\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Bipolar Disorder Therapeutics Global Market Report 2022: Increase in the Prevalence of Bipolar Disorder to Drive Growth &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-09-13T17:01:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\\\/\"},\"wordCount\":782,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220913006125\\\/en\\\/1570464\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\\\/\",\"name\":\"Bipolar Disorder Therapeutics Global Market Report 2022: Increase in the Prevalence of Bipolar Disorder to Drive Growth - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220913006125\\\/en\\\/1570464\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-09-13T17:01:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220913006125\\\/en\\\/1570464\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220913006125\\\/en\\\/1570464\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bipolar Disorder Therapeutics Global Market Report 2022: Increase in the Prevalence of Bipolar Disorder to Drive Growth &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bipolar Disorder Therapeutics Global Market Report 2022: Increase in the Prevalence of Bipolar Disorder to Drive Growth - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Bipolar Disorder Therapeutics Global Market Report 2022: Increase in the Prevalence of Bipolar Disorder to Drive Growth - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Bipolar Disorder Therapeutics Global Market Report 2022&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global bipolar disorder therapeutics market is expected to grow from $6.00 billion in 2021 to $6.47 billion in 2022 at a compound annual growth rate (CAGR) of 7.8%. The bipolar disorder therapeutics market is expected to grow to ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-13T17:01:52+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220913006125\/en\/1570464\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Bipolar Disorder Therapeutics Global Market Report 2022: Increase in the Prevalence of Bipolar Disorder to Drive Growth &#8211; ResearchAndMarkets.com","datePublished":"2022-09-13T17:01:52+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\/"},"wordCount":782,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220913006125\/en\/1570464\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\/","name":"Bipolar Disorder Therapeutics Global Market Report 2022: Increase in the Prevalence of Bipolar Disorder to Drive Growth - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220913006125\/en\/1570464\/21\/logo.jpg","datePublished":"2022-09-13T17:01:52+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220913006125\/en\/1570464\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220913006125\/en\/1570464\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/bipolar-disorder-therapeutics-global-market-report-2022-increase-in-the-prevalence-of-bipolar-disorder-to-drive-growth-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Bipolar Disorder Therapeutics Global Market Report 2022: Increase in the Prevalence of Bipolar Disorder to Drive Growth &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48327","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48327"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48327\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48327"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48327"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48327"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}